No Detail Found!

Noncoding RNAs: emerging modulators of ꞵ-globin regulation and ꞵ-hemoglobinopathies

Author(s)
Hamad Ali Department of Pharmaceutical Sciences, Pak-Austria Fachhochschule: Institute of Applied Sciences and Technology,Mang, Haripur, Khyber Pakhtunkhwa,Pakistan
Faisal Khan Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Abstract
B-Hemoglobinopathies, including B-thalassemia and sickle cell anemia, are the most common autosomal recessive disorders, globally. Non-coding RNAs (ncRNAs) are derived from exons or introns of protein-coding genes or intronic regions of noncoding genes. There is significant evidence that these ncRNAs may act as protein decoys to impact a variety of biological functions, signaling, transcriptional regulators, cell differentiation, morphogenesis, and developmental regulation. The aberrant regulation of ncRNA expression serves as a hallmark of many hematological disorders, and there is solid evidence that these RNA species can play key roles in the pathogenesis of B -hemoglobinopathies. In the present review, we provide a summary of recent research findings about the role of ncRNA in globin gene regulation and B -hemoglobinopathies and their potential as therapeutic targets or prognostic and diagnostic biomarkers.
Publication Details
Page(s) 173-189
Published Journal: Molecular Medicine Communications, Volume: 2, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
sickle cell anemia, hematopoiesis, Fetal Hemoglobin, ncRNA, therapeutic targets, B -thalassemia
0

Citations

0

Downloads

52

Views